Farmasøytiske produkter

Photorealistic close-up of a POMbrane crystalline membrane with 1nm pores for molecular filtration

Nature-inspired “POMbranes” use uniform 1-nanometer pores for ultra-selective molecular filtration

12. juni 2026 Rapportert av AI Bilde generert av AI Faktasjekket

Researchers from India and Singapore report a crystalline membrane made from polyoxometalate clusters whose intrinsic openings are about 1 nanometer wide, enabling unusually sharp molecular separations that could help lower energy use in some industrial purification and water-reuse steps.

Hong Kong advances plan for independent drug regulator with WHO recognition push

Hong Kong is recruiting for its Centre for Medical Products Regulation, expected to launch by the fourth quarter of 2026, as it seeks World Health Organization recognition and aims for independent drug approvals by 2030.

Laurus Labs stock rises 30 percent on FY26 results

25. juni 2026 Rapportert av AI

Laurus Labs reported strong financial results for fiscal 2026, driving a 30 percent gain in its share price. Growth in contract manufacturing and a better product mix supported the performance.

Afrika

Novo Nordisk heads to South African court over semaglutide copies

Afrika

Madbouly opens industrial expansions in automotive, pharmaceutical, and food sectors

Helse

Study links GLP-1 drugs to lower breast cancer risk

Study links PAM gene variants to weaker blood-sugar response to GLP-1 drugs such as Ozempic

Researchers say genetic variants in the PAM gene may help explain why some people with Type 2 diabetes get less blood-sugar benefit from GLP-1 receptor agonist drugs such as Ozempic, a phenomenon they describe as “GLP-1 resistance.”

Rameda appoints Sharif Ahmed El Akhdar as non-executive chairman

4. juni 2026 Rapportert av AI

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents has named Sharif Ahmed El Akhdar non-executive chairman following LVP Pharma’s investment. Two additional board members joined at the same time.

USC researchers identify compounds targeting Alzheimer’s brain inflammation

Scientists at the University of Southern California have found experimental compounds that may reduce harmful brain inflammation associated with Alzheimer’s disease. The work focuses on the enzyme cPLA2 and people who carry the high-risk APOE4 gene.

Sun Pharma reports strong quarterly growth but eyes margin pressure

24. mai 2026 Rapportert av AI

Sun Pharmaceutical Industries posted robust revenue and profit increases for the March quarter. The company noted pressure on EBITDA margins due to higher investments and reduced milestone income. Outlook for the next fiscal year points to steady but moderated expansion.

lørdag, 20. juni 2026, 18:44